Applied Therapeutics: AdCom Decision Takes Govorestat Approval A Step Closer
Applied Therapeutics(US:APLT) Seeking Alphaยท2024-09-19 13:16Group 1 - Applied Therapeutics, Inc. (NASDAQ: APLT) stock experienced a significant increase of nearly 70%, reaching approximately $8 per share, following the announcement of news related to its lead product [1] - The company is part of a marketplace channel that offers exclusive stock tips focused on Pharma, Biotech, and Healthcare, providing investment insights and financial models [1] - The investing group Haggerston BioHealth, led by a biotech consultant with over 5 years of experience, covers detailed reports on more than 1,000 companies in the biotech, healthcare, and pharma sectors [1]